Evidence on the human health effects of low-level methylmercury exposure.
Karagas MR, Choi AL, Oken E, Horvat M, Schoeny R, Kamai E, Cowell W, Grandjean P, Korrick S. · 2012
Read Evidence on the human health effects of low-level methylmercury exposure. by Karagas MR, Choi AL, Oken E, Horvat M, Schoeny R, Kamai E, Cowell W, Grandjean P, Korrick S. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3385440.txt.
Introduction
Karagas led a synthesis in 2012 of what low-level methylmercury exposure does to human health. This form of mercury, picked up mainly by eating fish, is a known nerve poison at high doses. The review excluded places with very high fish intake to focus on everyday exposure levels.
Recent studies hint that low exposure may slow fetal and infant growth in some groups. Effects on the developing brain seem to vary with age, sex, and timing of exposure. For heart disease, no clear pattern emerged across studies, and immune results were inconsistent. The authors ask for work on who is most susceptible and how the harm works, to guide food and safety policy.
Catalog record
| CREATOR | Karagas MR, Choi AL, Oken E, Horvat M, Schoeny R, Kamai E, Cowell W, Grandjean P, Korrick S. |
|---|---|
| YEAR | 2012 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| LICENSE | CC0 1.0 Universal |
| RIGHTS | CC0 |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Evidence on the Human Health Effects of Low-Level Methylmercury Exposure By Margaret R. Karagas, Anna L. Choi, Emily Oken, Milena Horvat, Rita Schoeny, Elizabeth Kamai, Whitney Cowell, Philippe Grandjean, Susan Korrick Published in: Environmental Health Perspectives DOI: 10.1289/ehp.1104494 ABSTRACT Background: Methylmercury (MeHg) is a known neuro-toxicant. Emerging evidence indicates it may have adverse effects on the neuro-logic and other body systems at common low levels of exposure. Impacts of MeHg exposure could vary by individual susceptibility or be confounded by bene-ficial nutrients in fish containing MeHg. Despite its global relevance, synthesis of the available literature on low-level MeHg exposure has been limited. Objectives: We undertook a synthesis of the current knowledge on the human health effects of low-level MeHg exposure to provide a basis for future research efforts, risk assessment, and exposure remediation policies worldwide. Data sources and extraction: We reviewed the published literature for original human epidemio-logic research articles that reported a direct biomarker of mercury exposure. To focus on high-quality studies and those specifically on low mercury exposure, we excluded case series, as well as studies of populations with unusually high fish consumption (e.g., the Seychelles), marine mammal consumption (e.g., the Faroe Islands, circumpolar, and other indigenous populations), or consumption of highly contaminated fish (e.g., gold-mining regions in the Amazon). Data synthesis: Recent evidence raises the possibility of effects of low-level MeHg exposure on fetal growth among susceptible subgroups and on infant growth in the first 2 years of life. Low-level effects of MeHg on neuro-logic outcomes may differ by age, sex, and timing of exposure. No clear pattern has been observed for cardio-vascular disease (CVD) risk across populations or for specific CVD end points. For the few studies evaluating immunologic effects associated with MeHg, results have been inconsistent. Conclusions: Studies targeted at identifying potential mechanisms of low-level MeHg effects and characterizing individual susceptibility, sexual dimorphism, and non-linearity in dose response would help guide future prevention, policy, and regulatory efforts surrounding MeHg exposure. Methylmercury (MeHg) from natural or anthropogenic sources biomagnifies through the food chain and gives rise to human exposure primarily through consumption of higher trophic level fish and marine mammals [National Research Council (NRC) 2000]. MeHg crosses the placenta and readily passes through the blood–brain barrier, with even higher MeHg levels in fetal than in maternal circulation (Stern and Smith 2003). Vulnerability of the developing fetus to MeHg exposure was exemplified in Minamata, Japan, when pregnant women consumed seafood highly contaminated with MeHg. This resulted in extreme fetal abnormalities and neuro-toxicity (i.e., microcephaly, blindness, severe mental and physical develop-mental retardation) even among infants born to mothers with minimal symptoms (Harada 1995). More subtle neurodevelopmental effects have been observed in populations with moderate MeHg exposures from regular consumption of fish and/or marine mammals, including associations of MeHg biomarkers at birth with decrements in memory, attention, language, and visual-motor skills in childhood (NRC 2000). Most recently, a growing body of literature has explored the impact of even lower levels of MeHg on a variety of health outcomes in both adults and children. Findings include potential adverse effects on fetal growth, neorulogic function, the cardio-vascular system, and immune function. Given that fish is a key source of dietary protein in much of the world, MeHg contamina-tion of fish has the potential to impact the health of geographically diverse populations. Furthermore, fish is an important source of bene-ficial nutrients such as poly-unsaturated fatty acids (PUFA), iodine, selenium, and vitamin D. Development of dietary recom-menda-tions that balance nutritional benefits of fish with the contami-nant risk has been a challenge for govern-ment regulatory agencies and public health professionals (Teisl et al. 2011). In this context, charac-teriza-tion of MeHg health risks is critical for the develop-ment of optimal fish consumption guidelines (Cohen et al. 2005a; Shimshack and Ward 2010). However, there has been limited, if any, synthesis of the available literature on the health effects of low-level MeHg exposure, despite its global relevance. To synthesize the current state of knowledge on the human health effects of low-level MeHg exposure, we focused on the epidemiologic literature of mercury concentrations measured in biologic tissue. We examined the following questions: a) What are the key health effects of lower, prevalent levels of MeHg exposure in the general population, and what are the strengths and limitations of recent evidence regarding those health effects? b) What are potential confounders or modifiers of human health risks (synergistic or antagonistic) at low-level exposure? c) What important gaps exist in the current literature? The ultimate goal of this review was to provide a basis for optimizing future research efforts, as well as risk–benefit assessment and exposure remediation policies, worldwide. BIOMARKERS OF MEHG EXPOSURE Biomarkers of MeHg exposure, such as total mercury levels in hair or blood, are regarded as more accurate measures of human exposure than dietary assessment (i.e., of fish consumption) because MeHg concentrations vary both between and within fish species and because recall of specific species may be imprecise (Groth 2010). Although it is correlated with maternal hair, cord blood mercury may better reflect fetal exposure than maternal hair (Grandjean et al. 2002). Mercury is excreted in breast milk, but it is not typically used as a matrix for assessing exposure, primarily because of low concentrations and variability in the proportion present as MeHg (Björnberg et al. 2005; García-Esquinas et al. 2011; Miklavcic et al. 2011). Meconium and other tissues, such as umbilical cord, placenta, and nail tissue, although potentially useful, have not been used widely in epidemio-logic studies (Gundacker et al. 2010; Rees et al. 2007). Urinary mercury reflects inorganic mercury levels and thus is not used as an indicator of MeHg exposure; however, in hair, nails, and blood, MeHg is the primary contributor to total mercury levels (Grandjean et al. 2002). Even the best exposure biomarkers are imprecise measures of MeHg in target organs such as the fetal brain. Furthermore, the average coefficient of variation is about 25% for cord blood mercury analysis and about twice that for maternal hair mercury (Grandjean and Budtz-Jørgensen 2010). Typically, imprecision in an exposure measure will attenuate its calculated effect (Rothman and Greenland 1998); this highlights the potential for measurement errors in MeHg exposure assessment to affect comparability of findings across studies. LOW-LEVEL EXPOSURE Because most of the published epidemiologic literature reports measures of total mercury rather than MeHg, we focused principally on studies with mercury exposure measures in blood or hair as matrices most reflective of MeHg. We excluded case reports or case series and reports that were not original research. We further limited our review to studies of low-dose mercury exposures, that is, we excluded analyses of the poisoning episodes in Japan and Iraq, as well as studies of popu-la-tions with mean measured mercury levels above any of the following: 4 µg/g in hair; 20 µg/L in cord blood, or approximately 12 µg/L in adult blood. We based our definition of low dose on a qualitative assessment of the literature and appreciation that findings from the three major cohort studies with moderate mercury exposures (the Faroe Islands, the Seychelles, and New Zealand) are already extensively reviewed (e.g., Axelrad et al. 2007; Cohen et al. 2005b; Rice 2004). Among the major prospective cohort studies of MeHg and child development in